Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Mesothelioma: HELP
Françoise Galateau-Sallé
Based on 32 articles published since 2007
||||
Expertise Level
The expertise of Françoise Galateau-Sallé ranks in the
  • Top 0.21%
  • ... of 15,808 published authors worldwide on Mesothelioma
  • ... from 2007 through 2018
  • ... based on contributions to 32 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Galateau-Sallé, Françoise   ·   Galateau-Salle, Françoise   ·   Galateau-Salle, Francoise   ·   Galateau-Sallé, Francoise
Work Locations
Details
Most likely:    Hospices Civils de Lyon      
2017
  • Department of Biopathology, National referent center MESOPATH-National Clinicobiologic Databasis MESOBANK, Cancer Center of Léon Bérard, Lyon, France; UGA/INSERM U1209/CNRS 5309-Institute for Advanced Biosciences-University Grenoble Alpes, Grenoble, France. Electronic address: · Department of Biopathology-Register MESONAT, Cancer Center of Léon Bérard, Lyon, France; INSERM UMR 1086, Cancers & Preventions, University Caen Basse-Normandie, Caen, France. · Department of Biopathology, National referent center MESOPATH-National Clinicobiologic Databasis MESOBANK, Cancer Center of Léon Bérard, Lyon, France. · University Lille, CHU Lille, MESOCLIN, Lille, France. · Department of Biopathology, National referent center MESOPATH-Base National Clinicobiologic Databasis MESOBANK Register multicenter MESONAT-Sante public cancer center of Léon Bérard, Lyon, France. · Pubmed 28434510
  • Department of Pathology Cedars-Sinai Medical Center, Los Angeles, CA. Electronic address: · Department of Pathology, MESOPATH-MESOBANK, Centre León Bérard, Lyon, France. · Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan. · Interhospital Pathology Division, Università degli Studi di Milano and IRCCS MultiMedica Group, Milan, Italy. · Department of Pathology University of Wales and Cardiff University, Cardiff, U.K. · Department of Pathology, University of British Columbia, Vancouver, BC. · Department of Pathology, Brigham and Women's Hospital, Boston, MA. · Department of Pathology UPMC-PUH, Pittsburgh, PA. · Department of Pathology, Chicago University, Chicago, IL. · Department of Pathology, Mayo Clinic, Jacksonville, FL. · SA Pathology at Flinders Medical Cemtre, Bedord Park, SA. · Department of Pathology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France. · Department of Pathology Duke University, Durham, NC. · Department of Pathology, CHU de Nancy, Nancy, France. · University Hospital Leuven, Leuven, Belgium. · Department of Pathology Sloan Kettering Memorial Cancer Center, New York, NY. · Department of Pathology Fukuoka University Hospital, Fukuoka, Japan. · Pubmed 28782639
  • International Agency for Research on Cancer, Lyon, France. · Structural and Functional Genomics Core Facility, University of Lille, Lille, France. · Department of Biopathology, Cancer Center Lyon Leon Berard, Lyon, France; National Cancer Institute, Research Unit 1086, Caen, France. · National Cancer Institute, Research Unit 1213, Lyon, France. · Faculty of Medicine, Research Team 3738, Lyon1 University, Oullins, France; French National Network for the Treatment of Rare Peritoneal Surface Malignancies, University Hospital of Lyon and Lyon1 University, Lyon, France; University Hospital of Lyon, Lyon, France. · Faculty of Medicine, Research Team 3738, Lyon1 University, Oullins, France; French National Network for the Treatment of Rare Peritoneal Surface Malignancies, University Hospital of Lyon and Lyon1 University, Lyon, France; Department of Pathology, University Hospital of Lyon and Lyon1 University, Lyon, France. · Department of Oncology, University Hospital of Lyon and Lyon1 University, Lyon, France. · Department of Radiology, University Hospital of Lyon and Lyon1 University, Lyon, France. · Structural and Functional Genomics Core Facility, University of Lille, Lille, France; Sequencing Platform, Research Cancer Institute, Lille, France. · Faculty of Medicine, Research Team 3738, Lyon1 University, Oullins, France; French National Network for the Treatment of Rare Peritoneal Surface Malignancies, University Hospital of Lyon and Lyon1 University, Lyon, France; Department of Surgery, University Hospital of Lyon and Lyon1 University, Lyon, France. · International Agency for Research on Cancer, Lyon, France. Electronic address: · Pubmed 28034829
2016
  • Department of Pathology, Centre Hospitalier Universitaire Caen, Caen, France; Department of Biopathology, Centre Leon Berard, Lyon, France. · Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Department of Pathology, Duke University Medical Center, Durham, NC, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 26811225
  • Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: · Cancer Research And Biostatistics, Seattle, Washington. · Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. · National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Department of Cardiothoracic Surgery, New York University Medical Center, New York, New York. · Department of Thoracic and Cardiovascular Surgery, M.D. Anderson Cancer Center, Houston, Texas. · Department of Biopathology, Centre Leon Berard, Lyon, France. · Sydney Cardiothoracic Surgeons, Royal Prince Alfred Medical Centre, Sydney, New South Wales, Australia. · Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan. · Department of Surgical Sciences, City of Health and Science Hospital, University of Turin, Turin, Italy. · Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium. · Department of Thoracic Surgery, Hyogo Cancer Center, Akashi City, Hyogo, Japan. · Pubmed 27687962
  • Département d'Anatomie et de Cytologie Pathologiques, Pôle de Biologie et de Pathologie, CHU A Michallon, CS 10217, 38043 Grenoble, France. · Département de Biopathologie MESOPATH, Centre Léon Bérard, 69008 Lyon, U1086 INSERM-UCBN "Cancers & Préventions", Caen, France. · Plateforme Hospitalière de Génétique Moléculaire des Cancers, Pôle de Biologie et de Pathologie, CHU A Michallon, CS 10217, 38043 Grenoble, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, 38700 La Tronche, France. · Département de Biopathologie - Registre MESONAT, Centre Léon Bérard, 69008 Lyon, U1086 INSERM-UCBN "Cancers & Préventions", Caen, France. · Unité d'Oncologie Thoracique, Clinique de Pneumologie, Pôle Thorax et Vaisseaux, CHU A Michallon, CS 10217, 38043 Grenoble, Université Joseph Fourier - INSERM U 823, Institut A. Bonniot, 38700 La Tronche, France. · Clinique Universitaire de Radiologie et Imagerie Médicale, CHU A Michallon, CS 10217, 38043 Grenoble, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, 38700 La Tronche, France. · Centre de Recherche en Cancérologie de Lyon, INSERM Unité Mixte de Recherche 1052/Centre National de la Recherche Scientifique 5286, Centre Léon Bérard, 69008 Lyon, France. · Département de Biopathologie, Centre Léon Bérard, 69008 Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, 38700 La Tronche, France. Electronic address: · Pubmed 26980049
  • From the Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada (Drs Churg and Sheffield); and Service Anatomie Pathologique, Centre National Référent MESOPATH, CHU du Caen, Caen, France (Dr Galateau-Salle). Dr Galateau-Salle is now with the Department of Pathology, Centre Leon Berard, Lyon, France. · Pubmed 26288396
2016
  • From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley). · Pubmed 27031777
Probable:    University of British Columbia      
2016
  • From the Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada (Drs Churg and Sheffield); and Service Anatomie Pathologique, Centre National Référent MESOPATH, CHU du Caen, Caen, France (Dr Galateau-Salle). Dr Galateau-Salle is now with the Department of Pathology, Centre Leon Berard, Lyon, France. · Pubmed 26288396
2018
  • From the Department of Pathology, University of Chicago Medical Center, Chicago, Illinois (Drs Husain and Krausz); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Dr Colby, emeritus); the Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston (Dr Ordóñez); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Cellular Pathology, University Hospital of Wales and Cardiff University, Cardiff, South Glamorgan, Wales (Dr Attanoos); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, University of Vermont College of Medicine, Burlington (Dr Butnor); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); Centre National Référent MESOPATH Departement de Biopathologie, Lyon Cedex, France (Dr Galateau-Sallé); the Department of Pathology, University Hospital of Wales, Penarth, South Glamorgan, Wales (Dr Gibbs); the Department of Pathology, PhenoPath Laboratories, Seattle, Washington (Dr Gown); the Department of Pathology & Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, (Dr Litzky); the Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California (Drs Marchevsky and Walts); the Department of Histopathology, Royal Brompton & Harefield National Health Service Foundation Trust and the National Heart and Lung Institute, Imperial College, Chelsea, London, England (Dr Nicholson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Department of Pathology, University of Pittsburgh, and the VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (Dr Sharma); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Travis); and the Department of Pathology, University of Virginia Medical Center, Charlottesville (Dr Wick). · Pubmed 28686500
2016
  • From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley). · Pubmed 27031777
2014
  • *Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada †Department of Pathology, The University of Texas Medical Branch Galveston §Department of Pathology and Genomic Medicine, Houston Methodist Hospital **Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ¶PhenoPath Laboratories, Seattle, WA ††Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale, AZ ‡‡Department of Pathology, University of Virginia Health System, Charlottesville, VA ∥Department of Pathology, CHU Caen, Caen, France #Department of Clinical Pathology, Ospedale dell'Angelo Venezia, Mestre, Italy. · Pubmed 24618613
2012
  • Department of Pathology, G227, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada. · Pubmed 23020727
Probable:    Miscellaneous institutions in Caen      
2016
  • Department of Surgery, Hospices Civils de Lyon (HCL) Cancer Institute, Lyon 1 University, 69310 Pierre-Bénite, France. · Department of Medical Oncology, HCL Cancer Institute, Lyon 1 University, 69310 Pierre-Bénite, France. · Lille University, Centre Hospitalier et Universitaire (CHU) Lille, Institut Recherche Sur Le Cancer (IRCL), Structural and Functional Genomics Core Facility, 59000 Lille, France. · Department of Pathology, HCL Cancer Institute, Lyon 1 University, 69577 Bron, France; Equipe Mixte de Recherche 3738, Lyon 1 University, Faculty of Medicine, 69310 Pierre-Bénite, France; Réseau National de Prise en Charge des Tumeurs Rares du Péritoine (RENAPE), HCL Cancer Institute and Lyon 1 University, Lyon, 69310 Pierre-Bénite, France. · Department of Surgery, Hospices Civils de Lyon (HCL) Cancer Institute, Lyon 1 University, 69310 Pierre-Bénite, France; Equipe Mixte de Recherche 3738, Lyon 1 University, Faculty of Medicine, 69310 Pierre-Bénite, France; Réseau National de Prise en Charge des Tumeurs Rares du Péritoine (RENAPE), HCL Cancer Institute and Lyon 1 University, Lyon, 69310 Pierre-Bénite, France. · Equipe Mixte de Recherche 3738, Lyon 1 University, Faculty of Medicine, 69310 Pierre-Bénite, France; Réseau National de Prise en Charge des Tumeurs Rares du Péritoine (RENAPE), HCL Cancer Institute and Lyon 1 University, Lyon, 69310 Pierre-Bénite, France; HCL, Pôle Information Médicale Evaluation Recherche (IMER), 69310 Pierre-Bénite, France. · Department of Medical Oncology, HCL Cancer Institute, Lyon 1 University, 69310 Pierre-Bénite, France; HCL, Biostatistics Unit, Lyon, Center National de la Recherche, Scientifique Unités Mixtes de Recherche (CNRS UMR) 5558, Biometry and Evolutionary Biology Laboratory, Health and Biostatistics Team, 69100 Villeurbanne, France. · InVentiv Medical Communications, London WC2H 8AL, UK. · Mésothéliomes Malins Pleuraux et Tumeurs Péritonéales Rares (MESOPATH)-IM@EC, CHU Caen, 14003 Caen, France. · Department of Pathology, HCL Cancer Institute, Lyon 1 University, 69577 Bron, France; Equipe Mixte de Recherche 3738, Lyon 1 University, Faculty of Medicine, 69310 Pierre-Bénite, France; Réseau National de Prise en Charge des Tumeurs Rares du Péritoine (RENAPE), HCL Cancer Institute and Lyon 1 University, Lyon, 69310 Pierre-Bénite, France. Electronic address: · Pubmed 27184482
2015
  • Service de santé au travail et pathologie professionnelle, CHU Caen, Caen, France INSERM, UMR 1086, Cancers et Populations, Caen, France Faculté de Médecine, Université de Caen, Caen, France. · INSERM, UMR 1086, Cancers et Populations, Caen, France. · Registre des tumeurs digestives du Calvados, Caen, France. · Service d'anatomopathologie, CHU Caen, Caen, France. · INSERM, UMR 1086, Cancers et Populations, Caen, France Faculté de Médecine, Université de Caen, Caen, France. · Service de santé au travail et pathologie professionnelle, CHU Caen, Caen, France. · EA7298 INGRES, Nancy, France CHU Nancy, Nancy, France Faculté de Médecine, Université de Lorraine, Nancy, France. · Service de Santé au travail, GISTAF, Condé-sur-Noireau, France. · INSERM, UMR 1086, Cancers et Populations, Caen, France Faculté de Médecine, Université de Caen, Caen, France Registre des tumeurs digestives du Calvados, Caen, France. · Pubmed 26304776
2014
  • Centre national référent cancers rares MESOPATH « mésothéliomes malins pleuraux et tumeurs péritonéales rares », CHU Caen Côte-de-Nacre, 14033 Caen cedex 9, France; Registre MESONAT, CHU Caen Côte-de-Nacre, 14033 Caen cedex 9, France. Electronic address: · Département santé travail, institut de veille sanitaire, 12, rue du Val-d'Osne, 94415 Saint-Maurice cedex, France. · Registre MESONAT, CHU Caen Côte-de-Nacre, 14033 Caen cedex 9, France. · ISPED-LSTE-ESSAT, 146, rue Leo-Saignat, 33076 Bordeaux cedex, France. · IIMTPIF, Inserm, U955, université Paris-Est Créteil (JCP, PA), CHI Créteil, 40, avenue de Verdun, 94010 Creteil cedex, France. · Oncologie thoracique, maladies de la plèvre et pneumologie interventionnelle, hôpital Nord, Aix-Marseille université, 13916 Marseille cedex 20, France. · Centre national référent cancers rares MESOPATH « mésothéliomes malins pleuraux et tumeurs péritonéales rares », CHU Caen Côte-de-Nacre, 14033 Caen cedex 9, France. · Service de pneumologie et oncologie thoracique, hôpital Calmette, CHRU de Lille, avenue Oscar-Lambret, 59037 Lille cedex, France; Unité Inserm 774, faculté de médecine Henri-Warembourg, université de Lille-II, 59045 Lille cedex, France. · Inserm, UMR-674, IUH, 75010 Paris, France. · International Prevention Research Institute, 69000 Lyon, France. · Pubmed 24630637
  • The University of Chicago Medical Center, 5841 South Maryland Avenue, Chicago, IL 60637, USA. Electronic address: · The University of Chicago Medical Center, 5841 South Maryland Avenue, Chicago, IL 60637, USA. · Llandough Hospital, Penlan Road, Llandough, Penarth, South Glamorgan, UK. · Tokyo Women's Medical University Yachiyo Medical Center, 477-96 Owada-Shinden, Yachiyo 276-8524, Japan. · Laboratoire d'Anatomie Pathalogique, Caen, France. · Pubmed 24440278
2013
  • Inserm BIMU1086, service de pathologie, CHRU, Caen cedex, France. · Pubmed 23954121
2007
2012
2011
  • Cancers and Populations, ERI3 INSERM, Faculty of Medicine, Caen University Hospital, Caen, France. · Pubmed 21406385
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 32 total) written by Françoise Galateau-Sallé about Mesothelioma:

  • Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. 2018
  • PD-L1 Testing for Immune Checkpoint Inhibitors in Mesothelioma: For Want of Anything Better? 2017
  • The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. 2017
  • BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas. 2017
  • The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification. 2016
  • The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma. 2016
  • Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array. 2016
  • Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR). 2016
  • Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas. 2016
  • New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet? 2016
Show List of Full Article Records
Google Searches

Learn more about Françoise Galateau-Sallé using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Hospices Civils de Lyon
University of British Columbia
Miscellaneous institutions in Caen
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Hospices Civils de Lyon
2017
  • Department of Biopathology, National referent center MESOPATH-National Clinicobiologic Databasis MESOBANK, Cancer Center of Léon Bérard, Lyon, France; UGA/INSERM U1209/CNRS 5309-Institute for Advanced Biosciences-University Grenoble Alpes, Grenoble, France. Electronic address: · Department of Biopathology-Register MESONAT, Cancer Center of Léon Bérard, Lyon, France; INSERM UMR 1086, Cancers & Preventions, University Caen Basse-Normandie, Caen, France. · Department of Biopathology, National referent center MESOPATH-National Clinicobiologic Databasis MESOBANK, Cancer Center of Léon Bérard, Lyon, France. · University Lille, CHU Lille, MESOCLIN, Lille, France. · Department of Biopathology, National referent center MESOPATH-Base National Clinicobiologic Databasis MESOBANK Register multicenter MESONAT-Sante public cancer center of Léon Bérard, Lyon, France. · Pubmed 28434510
  • Department of Pathology Cedars-Sinai Medical Center, Los Angeles, CA. Electronic address: · Department of Pathology, MESOPATH-MESOBANK, Centre León Bérard, Lyon, France. · Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan. · Interhospital Pathology Division, Università degli Studi di Milano and IRCCS MultiMedica Group, Milan, Italy. · Department of Pathology University of Wales and Cardiff University, Cardiff, U.K. · Department of Pathology, University of British Columbia, Vancouver, BC. · Department of Pathology, Brigham and Women's Hospital, Boston, MA. · Department of Pathology UPMC-PUH, Pittsburgh, PA. · Department of Pathology, Chicago University, Chicago, IL. · Department of Pathology, Mayo Clinic, Jacksonville, FL. · SA Pathology at Flinders Medical Cemtre, Bedord Park, SA. · Department of Pathology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France. · Department of Pathology Duke University, Durham, NC. · Department of Pathology, CHU de Nancy, Nancy, France. · University Hospital Leuven, Leuven, Belgium. · Department of Pathology Sloan Kettering Memorial Cancer Center, New York, NY. · Department of Pathology Fukuoka University Hospital, Fukuoka, Japan. · Pubmed 28782639
  • International Agency for Research on Cancer, Lyon, France. · Structural and Functional Genomics Core Facility, University of Lille, Lille, France. · Department of Biopathology, Cancer Center Lyon Leon Berard, Lyon, France; National Cancer Institute, Research Unit 1086, Caen, France. · National Cancer Institute, Research Unit 1213, Lyon, France. · Faculty of Medicine, Research Team 3738, Lyon1 University, Oullins, France; French National Network for the Treatment of Rare Peritoneal Surface Malignancies, University Hospital of Lyon and Lyon1 University, Lyon, France; University Hospital of Lyon, Lyon, France. · Faculty of Medicine, Research Team 3738, Lyon1 University, Oullins, France; French National Network for the Treatment of Rare Peritoneal Surface Malignancies, University Hospital of Lyon and Lyon1 University, Lyon, France; Department of Pathology, University Hospital of Lyon and Lyon1 University, Lyon, France. · Department of Oncology, University Hospital of Lyon and Lyon1 University, Lyon, France. · Department of Radiology, University Hospital of Lyon and Lyon1 University, Lyon, France. · Structural and Functional Genomics Core Facility, University of Lille, Lille, France; Sequencing Platform, Research Cancer Institute, Lille, France. · Faculty of Medicine, Research Team 3738, Lyon1 University, Oullins, France; French National Network for the Treatment of Rare Peritoneal Surface Malignancies, University Hospital of Lyon and Lyon1 University, Lyon, France; Department of Surgery, University Hospital of Lyon and Lyon1 University, Lyon, France. · International Agency for Research on Cancer, Lyon, France. Electronic address: · Pubmed 28034829
2016
  • Department of Pathology, Centre Hospitalier Universitaire Caen, Caen, France; Department of Biopathology, Centre Leon Berard, Lyon, France. · Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Department of Pathology, Duke University Medical Center, Durham, NC, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 26811225
  • Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: · Cancer Research And Biostatistics, Seattle, Washington. · Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. · National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Department of Cardiothoracic Surgery, New York University Medical Center, New York, New York. · Department of Thoracic and Cardiovascular Surgery, M.D. Anderson Cancer Center, Houston, Texas. · Department of Biopathology, Centre Leon Berard, Lyon, France. · Sydney Cardiothoracic Surgeons, Royal Prince Alfred Medical Centre, Sydney, New South Wales, Australia. · Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan. · Department of Surgical Sciences, City of Health and Science Hospital, University of Turin, Turin, Italy. · Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium. · Department of Thoracic Surgery, Hyogo Cancer Center, Akashi City, Hyogo, Japan. · Pubmed 27687962
  • Département d'Anatomie et de Cytologie Pathologiques, Pôle de Biologie et de Pathologie, CHU A Michallon, CS 10217, 38043 Grenoble, France. · Département de Biopathologie MESOPATH, Centre Léon Bérard, 69008 Lyon, U1086 INSERM-UCBN "Cancers & Préventions", Caen, France. · Plateforme Hospitalière de Génétique Moléculaire des Cancers, Pôle de Biologie et de Pathologie, CHU A Michallon, CS 10217, 38043 Grenoble, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, 38700 La Tronche, France. · Département de Biopathologie - Registre MESONAT, Centre Léon Bérard, 69008 Lyon, U1086 INSERM-UCBN "Cancers & Préventions", Caen, France. · Unité d'Oncologie Thoracique, Clinique de Pneumologie, Pôle Thorax et Vaisseaux, CHU A Michallon, CS 10217, 38043 Grenoble, Université Joseph Fourier - INSERM U 823, Institut A. Bonniot, 38700 La Tronche, France. · Clinique Universitaire de Radiologie et Imagerie Médicale, CHU A Michallon, CS 10217, 38043 Grenoble, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, 38700 La Tronche, France. · Centre de Recherche en Cancérologie de Lyon, INSERM Unité Mixte de Recherche 1052/Centre National de la Recherche Scientifique 5286, Centre Léon Bérard, 69008 Lyon, France. · Département de Biopathologie, Centre Léon Bérard, 69008 Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, 38700 La Tronche, France. Electronic address: · Pubmed 26980049
  • From the Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada (Drs Churg and Sheffield); and Service Anatomie Pathologique, Centre National Référent MESOPATH, CHU du Caen, Caen, France (Dr Galateau-Salle). Dr Galateau-Salle is now with the Department of Pathology, Centre Leon Berard, Lyon, France. · Pubmed 26288396
2016
  • From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley). · Pubmed 27031777
University of British Columbia
2016
  • From the Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada (Drs Churg and Sheffield); and Service Anatomie Pathologique, Centre National Référent MESOPATH, CHU du Caen, Caen, France (Dr Galateau-Salle). Dr Galateau-Salle is now with the Department of Pathology, Centre Leon Berard, Lyon, France. · Pubmed 26288396
2018
  • From the Department of Pathology, University of Chicago Medical Center, Chicago, Illinois (Drs Husain and Krausz); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Dr Colby, emeritus); the Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston (Dr Ordóñez); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Cellular Pathology, University Hospital of Wales and Cardiff University, Cardiff, South Glamorgan, Wales (Dr Attanoos); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, University of Vermont College of Medicine, Burlington (Dr Butnor); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); Centre National Référent MESOPATH Departement de Biopathologie, Lyon Cedex, France (Dr Galateau-Sallé); the Department of Pathology, University Hospital of Wales, Penarth, South Glamorgan, Wales (Dr Gibbs); the Department of Pathology, PhenoPath Laboratories, Seattle, Washington (Dr Gown); the Department of Pathology & Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, (Dr Litzky); the Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California (Drs Marchevsky and Walts); the Department of Histopathology, Royal Brompton & Harefield National Health Service Foundation Trust and the National Heart and Lung Institute, Imperial College, Chelsea, London, England (Dr Nicholson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Department of Pathology, University of Pittsburgh, and the VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (Dr Sharma); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Travis); and the Department of Pathology, University of Virginia Medical Center, Charlottesville (Dr Wick). · Pubmed 28686500
2016
  • From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley). · Pubmed 27031777
2014
  • *Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada †Department of Pathology, The University of Texas Medical Branch Galveston §Department of Pathology and Genomic Medicine, Houston Methodist Hospital **Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ¶PhenoPath Laboratories, Seattle, WA ††Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Scottsdale, AZ ‡‡Department of Pathology, University of Virginia Health System, Charlottesville, VA ∥Department of Pathology, CHU Caen, Caen, France #Department of Clinical Pathology, Ospedale dell'Angelo Venezia, Mestre, Italy. · Pubmed 24618613
2012
  • Department of Pathology, G227, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada. · Pubmed 23020727
Miscellaneous institutions in Caen
2016
  • Department of Surgery, Hospices Civils de Lyon (HCL) Cancer Institute, Lyon 1 University, 69310 Pierre-Bénite, France. · Department of Medical Oncology, HCL Cancer Institute, Lyon 1 University, 69310 Pierre-Bénite, France. · Lille University, Centre Hospitalier et Universitaire (CHU) Lille, Institut Recherche Sur Le Cancer (IRCL), Structural and Functional Genomics Core Facility, 59000 Lille, France. · Department of Pathology, HCL Cancer Institute, Lyon 1 University, 69577 Bron, France; Equipe Mixte de Recherche 3738, Lyon 1 University, Faculty of Medicine, 69310 Pierre-Bénite, France; Réseau National de Prise en Charge des Tumeurs Rares du Péritoine (RENAPE), HCL Cancer Institute and Lyon 1 University, Lyon, 69310 Pierre-Bénite, France. · Department of Surgery, Hospices Civils de Lyon (HCL) Cancer Institute, Lyon 1 University, 69310 Pierre-Bénite, France; Equipe Mixte de Recherche 3738, Lyon 1 University, Faculty of Medicine, 69310 Pierre-Bénite, France; Réseau National de Prise en Charge des Tumeurs Rares du Péritoine (RENAPE), HCL Cancer Institute and Lyon 1 University, Lyon, 69310 Pierre-Bénite, France. · Equipe Mixte de Recherche 3738, Lyon 1 University, Faculty of Medicine, 69310 Pierre-Bénite, France; Réseau National de Prise en Charge des Tumeurs Rares du Péritoine (RENAPE), HCL Cancer Institute and Lyon 1 University, Lyon, 69310 Pierre-Bénite, France; HCL, Pôle Information Médicale Evaluation Recherche (IMER), 69310 Pierre-Bénite, France. · Department of Medical Oncology, HCL Cancer Institute, Lyon 1 University, 69310 Pierre-Bénite, France; HCL, Biostatistics Unit, Lyon, Center National de la Recherche, Scientifique Unités Mixtes de Recherche (CNRS UMR) 5558, Biometry and Evolutionary Biology Laboratory, Health and Biostatistics Team, 69100 Villeurbanne, France. · InVentiv Medical Communications, London WC2H 8AL, UK. · Mésothéliomes Malins Pleuraux et Tumeurs Péritonéales Rares (MESOPATH)-IM@EC, CHU Caen, 14003 Caen, France. · Department of Pathology, HCL Cancer Institute, Lyon 1 University, 69577 Bron, France; Equipe Mixte de Recherche 3738, Lyon 1 University, Faculty of Medicine, 69310 Pierre-Bénite, France; Réseau National de Prise en Charge des Tumeurs Rares du Péritoine (RENAPE), HCL Cancer Institute and Lyon 1 University, Lyon, 69310 Pierre-Bénite, France. Electronic address: · Pubmed 27184482
2015
  • Service de santé au travail et pathologie professionnelle, CHU Caen, Caen, France INSERM, UMR 1086, Cancers et Populations, Caen, France Faculté de Médecine, Université de Caen, Caen, France. · INSERM, UMR 1086, Cancers et Populations, Caen, France. · Registre des tumeurs digestives du Calvados, Caen, France. · Service d'anatomopathologie, CHU Caen, Caen, France. · INSERM, UMR 1086, Cancers et Populations, Caen, France Faculté de Médecine, Université de Caen, Caen, France. · Service de santé au travail et pathologie professionnelle, CHU Caen, Caen, France. · EA7298 INGRES, Nancy, France CHU Nancy, Nancy, France Faculté de Médecine, Université de Lorraine, Nancy, France. · Service de Santé au travail, GISTAF, Condé-sur-Noireau, France. · INSERM, UMR 1086, Cancers et Populations, Caen, France Faculté de Médecine, Université de Caen, Caen, France Registre des tumeurs digestives du Calvados, Caen, France. · Pubmed 26304776
2014
  • Centre national référent cancers rares MESOPATH « mésothéliomes malins pleuraux et tumeurs péritonéales rares », CHU Caen Côte-de-Nacre, 14033 Caen cedex 9, France; Registre MESONAT, CHU Caen Côte-de-Nacre, 14033 Caen cedex 9, France. Electronic address: · Département santé travail, institut de veille sanitaire, 12, rue du Val-d'Osne, 94415 Saint-Maurice cedex, France. · Registre MESONAT, CHU Caen Côte-de-Nacre, 14033 Caen cedex 9, France. · ISPED-LSTE-ESSAT, 146, rue Leo-Saignat, 33076 Bordeaux cedex, France. · IIMTPIF, Inserm, U955, université Paris-Est Créteil (JCP, PA), CHI Créteil, 40, avenue de Verdun, 94010 Creteil cedex, France. · Oncologie thoracique, maladies de la plèvre et pneumologie interventionnelle, hôpital Nord, Aix-Marseille université, 13916 Marseille cedex 20, France. · Centre national référent cancers rares MESOPATH « mésothéliomes malins pleuraux et tumeurs péritonéales rares », CHU Caen Côte-de-Nacre, 14033 Caen cedex 9, France. · Service de pneumologie et oncologie thoracique, hôpital Calmette, CHRU de Lille, avenue Oscar-Lambret, 59037 Lille cedex, France; Unité Inserm 774, faculté de médecine Henri-Warembourg, université de Lille-II, 59045 Lille cedex, France. · Inserm, UMR-674, IUH, 75010 Paris, France. · International Prevention Research Institute, 69000 Lyon, France. · Pubmed 24630637
  • The University of Chicago Medical Center, 5841 South Maryland Avenue, Chicago, IL 60637, USA. Electronic address: · The University of Chicago Medical Center, 5841 South Maryland Avenue, Chicago, IL 60637, USA. · Llandough Hospital, Penlan Road, Llandough, Penarth, South Glamorgan, UK. · Tokyo Women's Medical University Yachiyo Medical Center, 477-96 Owada-Shinden, Yachiyo 276-8524, Japan. · Laboratoire d'Anatomie Pathalogique, Caen, France. · Pubmed 24440278
2013
  • Inserm BIMU1086, service de pathologie, CHRU, Caen cedex, France. · Pubmed 23954121
2007
2012
2011
  • Cancers and Populations, ERI3 INSERM, Faculty of Medicine, Caen University Hospital, Caen, France. · Pubmed 21406385
45 Other Locations Show
Yearly article counts 136145322212
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.